Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya

Irreversible visual loss due to retinal toxicity is one of the side effects of hydroxychloroquine (HCQ) therapy. The recent outbreak of the novel coronavirus-19 (COVID 19) has seen HCQ proposed as a possible treatment and prophylactic drug, leading to its increased use. Many are unaware of its ocula...

Descripción completa

Detalles Bibliográficos
Autores principales: Onyango, Oscar M., Sitati, Sarah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671192/
https://www.ncbi.nlm.nih.gov/pubmed/36204922
http://dx.doi.org/10.4103/aam.aam_118_21
_version_ 1784832487602520064
author Onyango, Oscar M.
Sitati, Sarah M.
author_facet Onyango, Oscar M.
Sitati, Sarah M.
author_sort Onyango, Oscar M.
collection PubMed
description Irreversible visual loss due to retinal toxicity is one of the side effects of hydroxychloroquine (HCQ) therapy. The recent outbreak of the novel coronavirus-19 (COVID 19) has seen HCQ proposed as a possible treatment and prophylactic drug, leading to its increased use. Many are unaware of its ocular side effects. We describe a case of HCQ-induced retinopathy in a 46-year-old female who was referred by a rheumatologist for routine eye review.
format Online
Article
Text
id pubmed-9671192
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-96711922022-11-18 Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya Onyango, Oscar M. Sitati, Sarah M. Ann Afr Med Case Report Irreversible visual loss due to retinal toxicity is one of the side effects of hydroxychloroquine (HCQ) therapy. The recent outbreak of the novel coronavirus-19 (COVID 19) has seen HCQ proposed as a possible treatment and prophylactic drug, leading to its increased use. Many are unaware of its ocular side effects. We describe a case of HCQ-induced retinopathy in a 46-year-old female who was referred by a rheumatologist for routine eye review. Wolters Kluwer - Medknow 2022 2022-09-26 /pmc/articles/PMC9671192/ /pubmed/36204922 http://dx.doi.org/10.4103/aam.aam_118_21 Text en Copyright: © 2022 Annals of African Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Onyango, Oscar M.
Sitati, Sarah M.
Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya
title Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya
title_full Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya
title_fullStr Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya
title_full_unstemmed Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya
title_short Retinal Toxicity from Chronic Hydroxychloroquine use in Kenya
title_sort retinal toxicity from chronic hydroxychloroquine use in kenya
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671192/
https://www.ncbi.nlm.nih.gov/pubmed/36204922
http://dx.doi.org/10.4103/aam.aam_118_21
work_keys_str_mv AT onyangooscarm retinaltoxicityfromchronichydroxychloroquineuseinkenya
AT sitatisarahm retinaltoxicityfromchronichydroxychloroquineuseinkenya

Ejemplares similares